Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

The Potential Role of Statins in Pneumonia

Author(s): Brandy Nakashima, Marcos I. Restrepo, Antonio Anzueto and Eric M. Mortensen

Volume 6 , Issue 3 , 2010

Page: [155 - 161] Pages: 7

DOI: 10.2174/157339810791526193

Price: $65

Abstract

Pneumonia is the second leading cause of hospitalization in the United States, and along with influenza is the 8th leading cause of death. The risk of death during a pneumonia-related hospitalization is significantly higher than from many other major causes of hospitalization, as in 2005 it caused 4.6 deaths per 100 discharges. Recent studies have suggested that the use of statins may lead to better outcomes for subjects hospitalized with pneumonia or other infectious diseases. In this article, we examine the possible underlying mechanisms that may result in a beneficial effect of statins on infectious diseases, and describe the existing research that has examined this association. Further studies are needed to determine whether the long-term use of statins for cardioprotective effects also provides protection for patients at risk for pneumonia, or may serve as an acute treatment for pneumonia patients who require hospitalization.

Keywords: HMG-CoA reductase inhibitor, pneumonia


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy